NASDAQ
Castle Biosciences, Inc. (CSTL) has a current ratio of 5.26x as of Tuesday, May 26, 2026. This represents a 41.25% decrease compared to its 12-month average of 8.95x. The current ratio measures a company's ability to cover short-term obligations by comparing current assets to current liabilities.
No price data available for this timeframe.